Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31,054 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis.
Lee SH, Lee YJ, Heo JH, Hur SH, Choi HH, Kim KJ, Kim JH, Park KH, Lee JH, Choi YJ, Lee SJ, Hong SJ, Ahn CM, Kim BK, Ko YG, Choi D, Hong MK, Jang Y, Kim JS. Lee SH, et al. Among authors: kim kj, kim bk, kim js, kim jh. J Am Coll Cardiol. 2023 Apr 11;81(14):1339-1349. doi: 10.1016/j.jacc.2023.02.007. J Am Coll Cardiol. 2023. PMID: 37019580 Free article. Clinical Trial.
Prognostic significance of simvastatin therapy in patients with ischemic heart failure who underwent percutaneous coronary intervention for acute myocardial infarction.
Hong YJ, Jeong MH, Hyun DW, Hur SH, Kim KB, Kim W, Lim SY, Lee SH, Hong SN, Kang DG, Yun KH, Kim KH, Lee YS, Park HW, Kim JH, Ahn YK, Cho JG, Park JC, Kang JC. Hong YJ, et al. Among authors: kim w, kim kb, kim kh, kim jh. Am J Cardiol. 2005 Mar 1;95(5):619-22. doi: 10.1016/j.amjcard.2004.10.039. Am J Cardiol. 2005. PMID: 15721103
A multicenter, randomized, open-label, therapeutic, and exploratory trial to evaluate the tolerability and efficacy of platelet glycoprotein IIb/IIIa receptor blocker (Clotinab) in high-risk patients with percutaneous coronary intervention.
Moon JY, Kim W, Kim JH, Ahn Y, Jeong MH, Kim YH, Hong MK, Park SW, Park SJ, Park S, Ko YG, Choi D, Jang Y. Moon JY, et al. Among authors: kim yh, kim w, kim jh. Yonsei Med J. 2008 Jun 30;49(3):389-99. doi: 10.3349/ymj.2008.49.3.389. Yonsei Med J. 2008. PMID: 18581587 Free PMC article. Clinical Trial.
Efficacy of triple anti-platelet therapy including cilostazol in acute myocardial infarction patients undergoing drug-eluting stent implantation.
Park KH, Jeong MH, Lee MG, Ko JS, Lee SE, Kang WY, Kim SH, Sim DS, Yoon NS, Youn HJ, Hong YJ, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC. Park KH, et al. Among authors: kim sh, kim jh. Korean Circ J. 2009 May;39(5):190-7. doi: 10.4070/kcj.2009.39.5.190. Epub 2009 May 28. Korean Circ J. 2009. PMID: 19949578 Free PMC article.
Impact of baseline plaque components on plaque progression in nonintervened coronary segments in patients with angina pectoris on rosuvastatin 10 mg/day.
Hong YJ, Jeong MH, Choi YH, Ma EH, Ko JS, Lee MG, Park KH, Sim DS, Yoon NS, Youn HJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC. Hong YJ, et al. Among authors: kim kh, kim jh. Am J Cardiol. 2010 Nov 1;106(9):1241-7. doi: 10.1016/j.amjcard.2010.06.046. Epub 2010 Sep 9. Am J Cardiol. 2010. PMID: 21029819
Value of early risk stratification using hemoglobin level and neutrophil-to-lymphocyte ratio in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Cho KH, Jeong MH, Ahmed K, Hachinohe D, Choi HS, Chang SY, Kim MC, Hwang SH, Park KH, Lee MG, Ko JS, Sim DS, Yoon NS, Yoon HJ, Hong YJ, Kim KH, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC. Cho KH, et al. Among authors: kim mc, kim kh, kim jh. Am J Cardiol. 2011 Mar 15;107(6):849-56. doi: 10.1016/j.amjcard.2010.10.067. Epub 2011 Jan 19. Am J Cardiol. 2011. PMID: 21247535
31,054 results
You have reached the last available page of results. Please see the User Guide for more information.